Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 172 | 2024 | 1239 | 20.940 |
Why?
|
Patient Satisfaction | 138 | 2024 | 3451 | 12.600 |
Why?
|
Mastectomy | 118 | 2024 | 1834 | 9.520 |
Why?
|
Quality of Life | 169 | 2024 | 13300 | 7.630 |
Why?
|
Breast Implants | 55 | 2024 | 411 | 6.850 |
Why?
|
Psychometrics | 67 | 2024 | 3049 | 5.770 |
Why?
|
Breast Neoplasms | 152 | 2024 | 21065 | 5.450 |
Why?
|
Esthetics | 31 | 2024 | 326 | 5.200 |
Why?
|
Breast Implantation | 31 | 2023 | 223 | 5.090 |
Why?
|
Surgery, Plastic | 26 | 2024 | 640 | 4.270 |
Why?
|
Cosmetic Techniques | 14 | 2024 | 148 | 3.950 |
Why?
|
Surgical Flaps | 56 | 2021 | 1666 | 3.200 |
Why?
|
Rhytidoplasty | 8 | 2016 | 68 | 2.590 |
Why?
|
Nipples | 18 | 2023 | 221 | 2.400 |
Why?
|
Face | 18 | 2024 | 1017 | 2.150 |
Why?
|
Bariatric Surgery | 13 | 2024 | 1006 | 1.900 |
Why?
|
Lymphedema | 10 | 2024 | 525 | 1.820 |
Why?
|
Skin Aging | 5 | 2016 | 141 | 1.740 |
Why?
|
Tissue Expansion Devices | 18 | 2022 | 156 | 1.720 |
Why?
|
Mastectomy, Segmental | 17 | 2023 | 965 | 1.660 |
Why?
|
Postoperative Complications | 63 | 2024 | 15680 | 1.640 |
Why?
|
Cicatrix | 6 | 2021 | 781 | 1.610 |
Why?
|
Weight Loss | 11 | 2023 | 2683 | 1.440 |
Why?
|
Female | 302 | 2024 | 391011 | 1.350 |
Why?
|
Self Report | 15 | 2020 | 3707 | 1.330 |
Why?
|
Reproducibility of Results | 46 | 2024 | 20048 | 1.330 |
Why?
|
Humans | 409 | 2024 | 760261 | 1.260 |
Why?
|
Body Image | 15 | 2023 | 634 | 1.230 |
Why?
|
Rejuvenation | 5 | 2014 | 106 | 1.180 |
Why?
|
Tissue Expansion | 14 | 2020 | 160 | 1.160 |
Why?
|
Monitoring, Ambulatory | 2 | 2021 | 353 | 1.140 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2022 | 464 | 1.120 |
Why?
|
Middle Aged | 188 | 2024 | 220175 | 1.100 |
Why?
|
Canada | 16 | 2024 | 2128 | 1.080 |
Why?
|
Breast | 13 | 2023 | 1980 | 1.060 |
Why?
|
Adult | 178 | 2024 | 219847 | 1.050 |
Why?
|
Qualitative Research | 25 | 2024 | 2958 | 1.030 |
Why?
|
Patient Education as Topic | 11 | 2018 | 2311 | 0.960 |
Why?
|
Mastectomy, Subcutaneous | 5 | 2018 | 56 | 0.910 |
Why?
|
Evidence-Based Medicine | 12 | 2019 | 3696 | 0.900 |
Why?
|
Wounds and Injuries | 5 | 2024 | 2477 | 0.900 |
Why?
|
Facial Neoplasms | 3 | 2021 | 125 | 0.900 |
Why?
|
Quality Improvement | 10 | 2024 | 3840 | 0.890 |
Why?
|
Aged | 123 | 2024 | 168995 | 0.840 |
Why?
|
Obesity, Morbid | 7 | 2024 | 1287 | 0.800 |
Why?
|
Motivation | 5 | 2022 | 1990 | 0.790 |
Why?
|
Carcinoma, Basal Cell | 3 | 2018 | 559 | 0.780 |
Why?
|
Cleft Lip | 8 | 2023 | 504 | 0.770 |
Why?
|
Young Adult | 65 | 2024 | 58673 | 0.760 |
Why?
|
Cleft Palate | 8 | 2023 | 587 | 0.750 |
Why?
|
Personal Satisfaction | 7 | 2022 | 643 | 0.750 |
Why?
|
Facial Nerve Diseases | 1 | 2021 | 49 | 0.740 |
Why?
|
Rhinoplasty | 4 | 2021 | 238 | 0.720 |
Why?
|
Skin Neoplasms | 10 | 2022 | 5797 | 0.720 |
Why?
|
Rectus Abdominis | 12 | 2020 | 103 | 0.700 |
Why?
|
Sexuality | 3 | 2018 | 170 | 0.700 |
Why?
|
Surgical Procedures, Operative | 7 | 2024 | 1919 | 0.690 |
Why?
|
Prospective Studies | 62 | 2024 | 54263 | 0.690 |
Why?
|
Facial Paralysis | 4 | 2021 | 345 | 0.690 |
Why?
|
Mohs Surgery | 3 | 2021 | 221 | 0.690 |
Why?
|
Alopecia | 1 | 2024 | 415 | 0.680 |
Why?
|
Self Concept | 5 | 2018 | 1037 | 0.670 |
Why?
|
Internationality | 3 | 2020 | 1005 | 0.670 |
Why?
|
Treatment Outcome | 77 | 2022 | 64947 | 0.660 |
Why?
|
Leg Injuries | 4 | 2022 | 177 | 0.660 |
Why?
|
Pressure Ulcer | 2 | 2020 | 155 | 0.650 |
Why?
|
Thoracic Surgical Procedures | 2 | 2023 | 347 | 0.640 |
Why?
|
Acne Vulgaris | 3 | 2024 | 355 | 0.640 |
Why?
|
Arm | 1 | 2021 | 583 | 0.610 |
Why?
|
Fatigue | 3 | 2021 | 1544 | 0.610 |
Why?
|
Follow-Up Studies | 49 | 2024 | 39254 | 0.610 |
Why?
|
Checklist | 7 | 2022 | 827 | 0.600 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2018 | 385 | 0.560 |
Why?
|
Blepharoplasty | 1 | 2017 | 60 | 0.540 |
Why?
|
Neoplasms | 11 | 2023 | 22066 | 0.530 |
Why?
|
Microsurgery | 14 | 2019 | 791 | 0.520 |
Why?
|
Silicone Gels | 2 | 2013 | 39 | 0.520 |
Why?
|
Aged, 80 and over | 45 | 2024 | 58947 | 0.520 |
Why?
|
Adaptation, Psychological | 7 | 2022 | 2628 | 0.510 |
Why?
|
Decision Making | 11 | 2020 | 3924 | 0.490 |
Why?
|
Sensation | 3 | 2022 | 331 | 0.490 |
Why?
|
General Surgery | 4 | 2023 | 1681 | 0.490 |
Why?
|
Transplantation, Autologous | 13 | 2022 | 2120 | 0.490 |
Why?
|
Upper Extremity | 5 | 2024 | 661 | 0.480 |
Why?
|
Male | 94 | 2024 | 359413 | 0.480 |
Why?
|
Reoperation | 12 | 2024 | 4292 | 0.480 |
Why?
|
Quality of Health Care | 5 | 2022 | 4361 | 0.470 |
Why?
|
Radiotherapy, Adjuvant | 12 | 2021 | 1790 | 0.470 |
Why?
|
Interviews as Topic | 11 | 2024 | 2656 | 0.460 |
Why?
|
Registries | 13 | 2023 | 8449 | 0.450 |
Why?
|
Silicones | 3 | 2016 | 227 | 0.440 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 9 | 2020 | 938 | 0.440 |
Why?
|
Health Status | 8 | 2023 | 4081 | 0.430 |
Why?
|
Preoperative Period | 3 | 2021 | 555 | 0.430 |
Why?
|
Thoracic Wall | 4 | 2013 | 199 | 0.430 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2019 | 10340 | 0.430 |
Why?
|
Adolescent | 49 | 2024 | 87747 | 0.430 |
Why?
|
Biomedical Research | 4 | 2016 | 3421 | 0.420 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 756 | 0.420 |
Why?
|
Obesity | 9 | 2022 | 12915 | 0.410 |
Why?
|
Skin | 3 | 2020 | 4468 | 0.410 |
Why?
|
Sodium Chloride | 3 | 2016 | 596 | 0.410 |
Why?
|
Burns | 4 | 2021 | 1865 | 0.410 |
Why?
|
Craniofacial Abnormalities | 4 | 2021 | 315 | 0.410 |
Why?
|
Carcinoma, Lobular | 2 | 2020 | 490 | 0.400 |
Why?
|
United States | 45 | 2024 | 72363 | 0.390 |
Why?
|
Patient-Centered Care | 5 | 2024 | 1416 | 0.390 |
Why?
|
Religion and Medicine | 1 | 2013 | 160 | 0.380 |
Why?
|
Muscle Weakness | 2 | 2013 | 413 | 0.380 |
Why?
|
Comprehension | 3 | 2024 | 613 | 0.380 |
Why?
|
Time Factors | 36 | 2020 | 40133 | 0.380 |
Why?
|
Cross-Sectional Studies | 23 | 2024 | 25928 | 0.370 |
Why?
|
Netherlands | 5 | 2022 | 2213 | 0.370 |
Why?
|
Skin Care | 1 | 2011 | 57 | 0.370 |
Why?
|
Head and Neck Neoplasms | 8 | 2018 | 2880 | 0.360 |
Why?
|
Journalism, Medical | 1 | 2010 | 73 | 0.350 |
Why?
|
Pain, Postoperative | 7 | 2021 | 1718 | 0.350 |
Why?
|
Chronic Disease | 4 | 2024 | 9283 | 0.350 |
Why?
|
Tissue and Organ Harvesting | 3 | 2009 | 377 | 0.340 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2020 | 167 | 0.340 |
Why?
|
Health Status Indicators | 3 | 2020 | 968 | 0.320 |
Why?
|
Gynecomastia | 2 | 2019 | 87 | 0.310 |
Why?
|
Retrospective Studies | 52 | 2024 | 80301 | 0.310 |
Why?
|
Free Tissue Flaps | 4 | 2019 | 327 | 0.310 |
Why?
|
Risk Assessment | 20 | 2020 | 24086 | 0.300 |
Why?
|
Physician-Patient Relations | 6 | 2024 | 3242 | 0.300 |
Why?
|
Health Care Reform | 1 | 2017 | 1245 | 0.300 |
Why?
|
Patients | 5 | 2023 | 906 | 0.290 |
Why?
|
Anxiety | 7 | 2024 | 4532 | 0.290 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1060 | 0.290 |
Why?
|
Weight Gain | 1 | 2017 | 2347 | 0.290 |
Why?
|
Lip | 2 | 2021 | 197 | 0.280 |
Why?
|
Consensus | 6 | 2023 | 3106 | 0.280 |
Why?
|
Choice Behavior | 1 | 2013 | 817 | 0.280 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1529 | 0.280 |
Why?
|
Patient Selection | 8 | 2021 | 4276 | 0.280 |
Why?
|
Survivors | 3 | 2016 | 2367 | 0.270 |
Why?
|
Skin Transplantation | 2 | 2015 | 1083 | 0.270 |
Why?
|
Bandages | 2 | 2021 | 270 | 0.270 |
Why?
|
Internship and Residency | 3 | 2023 | 5867 | 0.270 |
Why?
|
Venous Thrombosis | 5 | 2016 | 1293 | 0.260 |
Why?
|
Limb Salvage | 4 | 2022 | 466 | 0.260 |
Why?
|
Research Design | 11 | 2022 | 6181 | 0.260 |
Why?
|
Hospitals | 8 | 2024 | 3929 | 0.260 |
Why?
|
Carcinoma | 1 | 2017 | 2334 | 0.260 |
Why?
|
Feasibility Studies | 6 | 2024 | 5201 | 0.250 |
Why?
|
Focus Groups | 3 | 2024 | 1372 | 0.250 |
Why?
|
Attitude to Health | 2 | 2018 | 2028 | 0.250 |
Why?
|
Health Services Research | 1 | 2012 | 1811 | 0.250 |
Why?
|
Societies, Medical | 4 | 2021 | 3903 | 0.240 |
Why?
|
Needs Assessment | 2 | 2012 | 1137 | 0.240 |
Why?
|
Disclosure | 1 | 2010 | 738 | 0.240 |
Why?
|
Aging | 2 | 2014 | 8641 | 0.240 |
Why?
|
Physicians, Women | 2 | 2021 | 492 | 0.240 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7468 | 0.240 |
Why?
|
Postoperative Care | 8 | 2019 | 1478 | 0.240 |
Why?
|
Specialties, Surgical | 2 | 2022 | 389 | 0.240 |
Why?
|
Ontario | 2 | 2023 | 405 | 0.240 |
Why?
|
Prognosis | 17 | 2024 | 29636 | 0.230 |
Why?
|
Publishing | 4 | 2021 | 837 | 0.230 |
Why?
|
Breast Diseases | 1 | 2007 | 443 | 0.230 |
Why?
|
Developing Countries | 4 | 2024 | 2880 | 0.230 |
Why?
|
Patient Preference | 3 | 2020 | 921 | 0.230 |
Why?
|
Delphi Technique | 3 | 2023 | 824 | 0.230 |
Why?
|
Scalp | 1 | 2006 | 389 | 0.220 |
Why?
|
Vagina | 2 | 2006 | 842 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2015 | 4024 | 0.220 |
Why?
|
Logistic Models | 13 | 2017 | 13311 | 0.220 |
Why?
|
Lower Extremity | 4 | 2022 | 1196 | 0.220 |
Why?
|
Postoperative Period | 4 | 2018 | 1821 | 0.220 |
Why?
|
Implant Capsular Contracture | 2 | 2021 | 23 | 0.220 |
Why?
|
Ear | 2 | 2021 | 172 | 0.210 |
Why?
|
Emotions | 4 | 2022 | 2730 | 0.210 |
Why?
|
Mandibular Neoplasms | 2 | 2009 | 130 | 0.210 |
Why?
|
Bariatrics | 1 | 2023 | 36 | 0.210 |
Why?
|
Australia | 6 | 2023 | 1288 | 0.210 |
Why?
|
Faculty, Medical | 2 | 2021 | 1192 | 0.210 |
Why?
|
Mental Health | 1 | 2017 | 3206 | 0.210 |
Why?
|
Prosthesis Design | 3 | 2017 | 2127 | 0.200 |
Why?
|
Muscle, Skeletal | 5 | 2012 | 4923 | 0.200 |
Why?
|
Graft Survival | 7 | 2019 | 3793 | 0.200 |
Why?
|
Stress, Psychological | 2 | 2019 | 4440 | 0.200 |
Why?
|
Lymph Node Excision | 3 | 2023 | 1305 | 0.200 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2024 | 161 | 0.190 |
Why?
|
Headache Disorders | 1 | 2024 | 148 | 0.190 |
Why?
|
Cellulitis | 2 | 2021 | 208 | 0.190 |
Why?
|
Analysis of Variance | 4 | 2016 | 6242 | 0.190 |
Why?
|
Sunburn | 1 | 2022 | 156 | 0.190 |
Why?
|
Healthcare Disparities | 2 | 2016 | 3381 | 0.190 |
Why?
|
Reference Values | 3 | 2023 | 4920 | 0.180 |
Why?
|
Epigastric Arteries | 3 | 2018 | 92 | 0.180 |
Why?
|
Hair | 1 | 2024 | 492 | 0.180 |
Why?
|
Physician Executives | 1 | 2021 | 133 | 0.180 |
Why?
|
Enoxaparin | 3 | 2012 | 397 | 0.180 |
Why?
|
Contracture | 2 | 2022 | 235 | 0.180 |
Why?
|
Telemedicine | 4 | 2024 | 3005 | 0.180 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1470 | 0.180 |
Why?
|
Genitalia, Female | 1 | 2021 | 147 | 0.180 |
Why?
|
Clinical Trials, Phase I as Topic | 2 | 2020 | 326 | 0.180 |
Why?
|
Quality Indicators, Health Care | 2 | 2023 | 1822 | 0.180 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5324 | 0.180 |
Why?
|
Benchmarking | 4 | 2024 | 1043 | 0.180 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 157 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 9274 | 0.170 |
Why?
|
New York City | 4 | 2016 | 723 | 0.170 |
Why?
|
Linear Models | 5 | 2018 | 5876 | 0.170 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 118 | 0.170 |
Why?
|
Risk Adjustment | 2 | 2020 | 601 | 0.170 |
Why?
|
Child | 27 | 2023 | 79758 | 0.170 |
Why?
|
Age Factors | 10 | 2017 | 18415 | 0.170 |
Why?
|
Ear Diseases | 1 | 2021 | 177 | 0.160 |
Why?
|
Hand | 2 | 2019 | 903 | 0.160 |
Why?
|
Prosthesis Failure | 2 | 2019 | 1206 | 0.160 |
Why?
|
Striae Distensae | 1 | 2018 | 7 | 0.160 |
Why?
|
Group Practice | 1 | 2020 | 151 | 0.160 |
Why?
|
Thorax | 2 | 2019 | 553 | 0.160 |
Why?
|
Health Priorities | 1 | 2022 | 376 | 0.160 |
Why?
|
Soft Tissue Neoplasms | 4 | 2008 | 1151 | 0.160 |
Why?
|
Cross-Cultural Comparison | 2 | 2019 | 632 | 0.160 |
Why?
|
Personnel Selection | 1 | 2020 | 193 | 0.150 |
Why?
|
Decision Trees | 3 | 2016 | 506 | 0.150 |
Why?
|
Dermatology | 4 | 2012 | 914 | 0.150 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2021 | 306 | 0.150 |
Why?
|
Multivariate Analysis | 7 | 2013 | 12156 | 0.150 |
Why?
|
Odds Ratio | 4 | 2023 | 9712 | 0.150 |
Why?
|
Capital Financing | 1 | 2018 | 59 | 0.150 |
Why?
|
Sex Reassignment Procedures | 1 | 2018 | 64 | 0.150 |
Why?
|
Ambulatory Care Facilities | 2 | 2021 | 926 | 0.150 |
Why?
|
Surgical Mesh | 1 | 2021 | 315 | 0.150 |
Why?
|
Denmark | 1 | 2020 | 759 | 0.150 |
Why?
|
Leadership | 3 | 2021 | 1372 | 0.150 |
Why?
|
Research Subjects | 1 | 2019 | 249 | 0.150 |
Why?
|
Venous Thromboembolism | 4 | 2012 | 1866 | 0.150 |
Why?
|
Wound Healing | 3 | 2024 | 2786 | 0.150 |
Why?
|
Neoplasm Invasiveness | 5 | 2019 | 3618 | 0.140 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.140 |
Why?
|
Dermatologic Agents | 2 | 2011 | 306 | 0.140 |
Why?
|
Anticoagulants | 6 | 2012 | 4896 | 0.140 |
Why?
|
Incidence | 13 | 2020 | 21378 | 0.140 |
Why?
|
Combined Modality Therapy | 9 | 2014 | 8551 | 0.140 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 710 | 0.140 |
Why?
|
Databases, Factual | 8 | 2019 | 8018 | 0.140 |
Why?
|
Physical Therapy Modalities | 4 | 2013 | 536 | 0.140 |
Why?
|
Genes, BRCA2 | 2 | 2020 | 604 | 0.140 |
Why?
|
Mastectomy, Modified Radical | 2 | 2010 | 62 | 0.130 |
Why?
|
Neoadjuvant Therapy | 4 | 2021 | 2811 | 0.130 |
Why?
|
Arabidopsis Proteins | 1 | 2018 | 263 | 0.130 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1078 | 0.130 |
Why?
|
Genes, BRCA1 | 2 | 2020 | 769 | 0.130 |
Why?
|
Cohort Studies | 17 | 2024 | 41317 | 0.130 |
Why?
|
Mastectomy, Radical | 1 | 2015 | 19 | 0.130 |
Why?
|
Psoriasis | 1 | 2024 | 939 | 0.130 |
Why?
|
Pilot Projects | 6 | 2024 | 8553 | 0.130 |
Why?
|
Hypertrophy | 1 | 2017 | 555 | 0.120 |
Why?
|
Algorithms | 10 | 2020 | 13967 | 0.120 |
Why?
|
Regression Analysis | 4 | 2023 | 6361 | 0.120 |
Why?
|
Cost Control | 1 | 2017 | 630 | 0.120 |
Why?
|
Cost-Benefit Analysis | 3 | 2018 | 5507 | 0.120 |
Why?
|
Preoperative Care | 4 | 2013 | 2255 | 0.120 |
Why?
|
Hernia, Diaphragmatic | 1 | 1995 | 246 | 0.120 |
Why?
|
Clinical Competence | 2 | 2023 | 4786 | 0.120 |
Why?
|
Cancer Care Facilities | 4 | 2019 | 425 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2015 | 983 | 0.120 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15827 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1348 | 0.110 |
Why?
|
Nose | 1 | 2017 | 519 | 0.110 |
Why?
|
Abdominal Wall | 2 | 2019 | 166 | 0.110 |
Why?
|
Chlorhexidine | 1 | 2015 | 160 | 0.110 |
Why?
|
Survival Rate | 6 | 2019 | 12806 | 0.110 |
Why?
|
Communication | 5 | 2024 | 3846 | 0.110 |
Why?
|
SOX Transcription Factors | 1 | 2013 | 7 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 576 | 0.110 |
Why?
|
Epidemiologic Methods | 2 | 2008 | 1344 | 0.110 |
Why?
|
Aftercare | 1 | 2019 | 918 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2024 | 1399 | 0.110 |
Why?
|
British Columbia | 1 | 2013 | 240 | 0.110 |
Why?
|
Forecasting | 2 | 2020 | 2931 | 0.110 |
Why?
|
Selection Bias | 1 | 2015 | 358 | 0.110 |
Why?
|
Prosthesis-Related Infections | 2 | 2009 | 486 | 0.110 |
Why?
|
Morbidity | 2 | 2020 | 1765 | 0.110 |
Why?
|
Neoplasm Staging | 8 | 2017 | 11141 | 0.110 |
Why?
|
Anti-Infective Agents, Local | 1 | 2015 | 247 | 0.100 |
Why?
|
Sarcoma | 3 | 2008 | 1786 | 0.100 |
Why?
|
Coitus | 1 | 2012 | 131 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3074 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 705 | 0.100 |
Why?
|
Gastric Bypass | 1 | 2020 | 826 | 0.100 |
Why?
|
Overweight | 2 | 2022 | 2421 | 0.100 |
Why?
|
Gastrectomy | 2 | 2020 | 677 | 0.100 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2011 | 346 | 0.100 |
Why?
|
Cultural Characteristics | 1 | 2013 | 253 | 0.100 |
Why?
|
Health Care Costs | 2 | 2018 | 3257 | 0.100 |
Why?
|
Hematoma | 3 | 2012 | 769 | 0.100 |
Why?
|
Sickness Impact Profile | 1 | 2012 | 298 | 0.100 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 664 | 0.090 |
Why?
|
Necrosis | 5 | 2018 | 1612 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 2018 | 1272 | 0.090 |
Why?
|
Computer Simulation | 3 | 2019 | 6210 | 0.090 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3466 | 0.090 |
Why?
|
Temperament | 1 | 2013 | 295 | 0.090 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2178 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 725 | 0.090 |
Why?
|
Treatment Failure | 4 | 2020 | 2646 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 951 | 0.090 |
Why?
|
Sunscreening Agents | 2 | 2022 | 139 | 0.090 |
Why?
|
Congresses as Topic | 4 | 2020 | 804 | 0.090 |
Why?
|
Thoracic Arteries | 1 | 2010 | 40 | 0.090 |
Why?
|
Self-Assessment | 1 | 2012 | 393 | 0.090 |
Why?
|
Physical Fitness | 2 | 2012 | 732 | 0.090 |
Why?
|
Device Removal | 4 | 2021 | 634 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3159 | 0.090 |
Why?
|
Pain | 3 | 2024 | 5066 | 0.090 |
Why?
|
Fat Necrosis | 1 | 2010 | 60 | 0.090 |
Why?
|
Travel | 1 | 2016 | 786 | 0.090 |
Why?
|
Mammary Arteries | 1 | 2010 | 81 | 0.080 |
Why?
|
Students, Medical | 1 | 2023 | 1926 | 0.080 |
Why?
|
Collagen | 3 | 2012 | 2635 | 0.080 |
Why?
|
Risk Factors | 15 | 2020 | 74269 | 0.080 |
Why?
|
Skull Base Neoplasms | 1 | 2013 | 269 | 0.080 |
Why?
|
Guidelines as Topic | 2 | 2017 | 1395 | 0.080 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2020 | 1094 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1266 | 0.080 |
Why?
|
Neck | 1 | 2014 | 730 | 0.080 |
Why?
|
Counseling | 3 | 2022 | 1550 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8058 | 0.080 |
Why?
|
Dermis | 1 | 2010 | 202 | 0.080 |
Why?
|
Poisson Distribution | 3 | 2015 | 507 | 0.080 |
Why?
|
Exercise | 4 | 2013 | 5783 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2022 | 3870 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 538 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1186 | 0.080 |
Why?
|
Recovery of Function | 3 | 2017 | 2982 | 0.080 |
Why?
|
Income | 3 | 2023 | 1876 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2783 | 0.080 |
Why?
|
Cutaneous Fistula | 1 | 2008 | 79 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 830 | 0.080 |
Why?
|
Ketorolac | 1 | 2009 | 94 | 0.080 |
Why?
|
Laparoscopy | 1 | 2020 | 2155 | 0.080 |
Why?
|
Review Literature as Topic | 1 | 2010 | 350 | 0.080 |
Why?
|
Software | 2 | 2019 | 4420 | 0.080 |
Why?
|
Expert Testimony | 1 | 2010 | 361 | 0.070 |
Why?
|
Pain Measurement | 4 | 2021 | 3514 | 0.070 |
Why?
|
Pharyngeal Diseases | 1 | 2008 | 134 | 0.070 |
Why?
|
Feedback | 2 | 2023 | 791 | 0.070 |
Why?
|
Interview, Psychological | 1 | 2010 | 812 | 0.070 |
Why?
|
Workload | 1 | 2013 | 846 | 0.070 |
Why?
|
Funnel Chest | 1 | 2008 | 74 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2332 | 0.070 |
Why?
|
Cost of Illness | 1 | 2017 | 1940 | 0.070 |
Why?
|
Gene Silencing | 1 | 2013 | 1511 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2013 | 1582 | 0.070 |
Why?
|
Pelvic Exenteration | 1 | 2006 | 21 | 0.070 |
Why?
|
Mouth | 1 | 2009 | 380 | 0.070 |
Why?
|
Fistula | 1 | 2008 | 214 | 0.070 |
Why?
|
Hypopharynx | 1 | 2006 | 53 | 0.070 |
Why?
|
Disease-Free Survival | 5 | 2016 | 6830 | 0.070 |
Why?
|
Primary Health Care | 1 | 2023 | 4649 | 0.070 |
Why?
|
Dysphonia | 1 | 2009 | 144 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3475 | 0.070 |
Why?
|
Employment | 2 | 2023 | 1111 | 0.070 |
Why?
|
Suction | 1 | 2007 | 263 | 0.070 |
Why?
|
Thumb | 1 | 2008 | 232 | 0.070 |
Why?
|
Skin, Artificial | 1 | 2006 | 89 | 0.070 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 2544 | 0.070 |
Why?
|
Leg | 1 | 2011 | 1091 | 0.070 |
Why?
|
Omentum | 1 | 2006 | 169 | 0.060 |
Why?
|
Skull Neoplasms | 1 | 2006 | 173 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14482 | 0.060 |
Why?
|
Pelvic Floor | 1 | 2006 | 142 | 0.060 |
Why?
|
Body Mass Index | 6 | 2022 | 12901 | 0.060 |
Why?
|
Activities of Daily Living | 2 | 2012 | 2414 | 0.060 |
Why?
|
Bupivacaine | 1 | 2009 | 413 | 0.060 |
Why?
|
Depression | 4 | 2020 | 8033 | 0.060 |
Why?
|
Shoulder | 1 | 2007 | 299 | 0.060 |
Why?
|
Thigh | 1 | 2006 | 239 | 0.060 |
Why?
|
Mandible | 1 | 2009 | 749 | 0.060 |
Why?
|
Graft Rejection | 2 | 2016 | 4423 | 0.060 |
Why?
|
Jejunum | 1 | 2006 | 472 | 0.060 |
Why?
|
Europe | 2 | 2024 | 3433 | 0.060 |
Why?
|
Bibliometrics | 2 | 2022 | 351 | 0.060 |
Why?
|
Survival Analysis | 5 | 2016 | 10185 | 0.060 |
Why?
|
Stockings, Compression | 1 | 2024 | 37 | 0.060 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2008 | 387 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 936 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2861 | 0.060 |
Why?
|
Propensity Score | 2 | 2022 | 1918 | 0.060 |
Why?
|
Postoperative Hemorrhage | 1 | 2007 | 422 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15273 | 0.050 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2008 | 633 | 0.050 |
Why?
|
Melanoma | 2 | 2015 | 5695 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2008 | 2018 | 0.050 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2003 | 51 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5793 | 0.050 |
Why?
|
Chordoma | 1 | 2006 | 346 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2804 | 0.050 |
Why?
|
American Cancer Society | 2 | 2012 | 62 | 0.050 |
Why?
|
Radiography, Panoramic | 1 | 2002 | 118 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6797 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2277 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8621 | 0.050 |
Why?
|
Information Dissemination | 1 | 2010 | 1132 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2013 | 7803 | 0.050 |
Why?
|
Craniotomy | 1 | 2006 | 741 | 0.050 |
Why?
|
Protective Clothing | 1 | 2022 | 103 | 0.050 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2022 | 3967 | 0.050 |
Why?
|
Biocompatible Materials | 1 | 2010 | 1689 | 0.050 |
Why?
|
Anesthetics, Local | 1 | 2009 | 1001 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2056 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 2282 | 0.050 |
Why?
|
Dextrans | 1 | 2003 | 574 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3293 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 317 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2283 | 0.050 |
Why?
|
Nigeria | 1 | 2024 | 762 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2017 | 3531 | 0.050 |
Why?
|
Pectoralis Muscles | 1 | 2021 | 85 | 0.040 |
Why?
|
Heparin | 1 | 2008 | 1655 | 0.040 |
Why?
|
Polymethyl Methacrylate | 2 | 2011 | 131 | 0.040 |
Why?
|
Fees, Pharmaceutical | 1 | 2020 | 66 | 0.040 |
Why?
|
Health Behavior | 2 | 2022 | 2621 | 0.040 |
Why?
|
New Zealand | 1 | 2020 | 355 | 0.040 |
Why?
|
Durapatite | 2 | 2011 | 163 | 0.040 |
Why?
|
Chile | 1 | 2020 | 254 | 0.040 |
Why?
|
Authorship | 1 | 2022 | 281 | 0.040 |
Why?
|
Biomedical Technology | 1 | 2022 | 211 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2011 | 12412 | 0.040 |
Why?
|
Bone Plates | 1 | 2002 | 465 | 0.040 |
Why?
|
Polyesters | 2 | 2011 | 372 | 0.040 |
Why?
|
Axilla | 1 | 2021 | 618 | 0.040 |
Why?
|
Medicare | 1 | 2017 | 6771 | 0.040 |
Why?
|
Seroma | 2 | 2010 | 76 | 0.040 |
Why?
|
Child, Preschool | 9 | 2017 | 42034 | 0.040 |
Why?
|
Surface Properties | 1 | 2021 | 1158 | 0.040 |
Why?
|
Feeding Behavior | 2 | 2021 | 3185 | 0.040 |
Why?
|
Bone Resorption | 1 | 2002 | 720 | 0.040 |
Why?
|
Thrombosis | 3 | 2008 | 3052 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17766 | 0.040 |
Why?
|
Speech Disorders | 1 | 2019 | 180 | 0.040 |
Why?
|
Publications | 1 | 2020 | 194 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2020 | 1628 | 0.040 |
Why?
|
Smoking | 3 | 2014 | 9070 | 0.040 |
Why?
|
Microcirculation | 3 | 2008 | 1279 | 0.040 |
Why?
|
Hyaluronic Acid | 2 | 2011 | 482 | 0.040 |
Why?
|
Italy | 1 | 2019 | 840 | 0.040 |
Why?
|
Computers, Handheld | 1 | 2019 | 210 | 0.040 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 727 | 0.040 |
Why?
|
Facial Asymmetry | 1 | 2018 | 172 | 0.040 |
Why?
|
Goals | 1 | 2022 | 708 | 0.030 |
Why?
|
Clinical Clerkship | 1 | 2023 | 563 | 0.030 |
Why?
|
Computers | 1 | 2019 | 595 | 0.030 |
Why?
|
Family Characteristics | 1 | 2021 | 1001 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2020 | 1035 | 0.030 |
Why?
|
North America | 1 | 2020 | 1282 | 0.030 |
Why?
|
Hand Injuries | 1 | 2019 | 239 | 0.030 |
Why?
|
Lactic Acid | 2 | 2011 | 1132 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2008 | 2532 | 0.030 |
Why?
|
Ductus Arteriosus | 1 | 1995 | 44 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1576 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6855 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1995 | 80 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5333 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 903 | 0.030 |
Why?
|
Disability Evaluation | 2 | 2012 | 1826 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5248 | 0.030 |
Why?
|
Patient Participation | 1 | 2024 | 1437 | 0.030 |
Why?
|
Role | 1 | 2015 | 177 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2295 | 0.030 |
Why?
|
Photography | 1 | 2017 | 530 | 0.030 |
Why?
|
Sexual Behavior | 2 | 2017 | 2080 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.030 |
Why?
|
Developed Countries | 1 | 2017 | 443 | 0.030 |
Why?
|
New York | 1 | 2016 | 874 | 0.030 |
Why?
|
Polymers | 2 | 2011 | 1620 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1066 | 0.030 |
Why?
|
Abdomen | 1 | 2019 | 1124 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 2002 | 1151 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2945 | 0.030 |
Why?
|
Geography | 1 | 2016 | 661 | 0.030 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1995 | 227 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 2014 | 189 | 0.030 |
Why?
|
Language | 1 | 2023 | 1532 | 0.030 |
Why?
|
Compression Bandages | 1 | 2013 | 14 | 0.030 |
Why?
|
History, 20th Century | 1 | 2021 | 2777 | 0.030 |
Why?
|
Cranial Fossa, Middle | 1 | 2013 | 29 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2014 | 8984 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2893 | 0.030 |
Why?
|
Vascular Patency | 1 | 2015 | 901 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 375 | 0.030 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2012 | 116 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2022 | 4763 | 0.030 |
Why?
|
Rural Population | 1 | 2022 | 2267 | 0.020 |
Why?
|
Hospital Charges | 1 | 2014 | 359 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2013 | 223 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1118 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2018 | 2434 | 0.020 |
Why?
|
Prevalence | 2 | 2019 | 15687 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2753 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1008 | 0.020 |
Why?
|
Massachusetts | 1 | 2024 | 8805 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11341 | 0.020 |
Why?
|
Narcotics | 1 | 2012 | 336 | 0.020 |
Why?
|
Suture Techniques | 1 | 2015 | 788 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2011 | 200 | 0.020 |
Why?
|
Health Expenditures | 1 | 2023 | 2359 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2011 | 679 | 0.020 |
Why?
|
Skull Base | 1 | 2013 | 291 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2021 | 3491 | 0.020 |
Why?
|
Policy Making | 1 | 2013 | 539 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2222 | 0.020 |
Why?
|
Beauty | 1 | 2009 | 41 | 0.020 |
Why?
|
Skin Diseases | 1 | 2018 | 1089 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2016 | 1724 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1056 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13249 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1161 | 0.020 |
Why?
|
DNA Methylation | 2 | 2013 | 4374 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1577 | 0.020 |
Why?
|
Social Support | 1 | 2018 | 2145 | 0.020 |
Why?
|
Models, Organizational | 1 | 2012 | 545 | 0.020 |
Why?
|
Science | 1 | 2011 | 240 | 0.020 |
Why?
|
Deglutition | 1 | 2009 | 208 | 0.020 |
Why?
|
Mobility Limitation | 1 | 2012 | 402 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1297 | 0.020 |
Why?
|
Muscle Strength | 1 | 2012 | 619 | 0.020 |
Why?
|
Mutation | 3 | 2020 | 29950 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2627 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2008 | 250 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 2009 | 292 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 488 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 1995 | 1328 | 0.020 |
Why?
|
Fibula | 1 | 2009 | 265 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2013 | 8498 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2696 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1181 | 0.020 |
Why?
|
Palliative Care | 1 | 2022 | 3607 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2008 | 516 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1897 | 0.020 |
Why?
|
Laryngectomy | 1 | 2008 | 243 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3605 | 0.020 |
Why?
|
Sacrococcygeal Region | 1 | 2006 | 53 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 2057 | 0.020 |
Why?
|
Health Surveys | 1 | 2016 | 4061 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2012 | 1439 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2852 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2668 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6131 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1200 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2013 | 1183 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4573 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3327 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10552 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5039 | 0.020 |
Why?
|
Soft Tissue Injuries | 1 | 2007 | 172 | 0.020 |
Why?
|
Gene Library | 1 | 2008 | 1060 | 0.020 |
Why?
|
Radiography | 2 | 2008 | 6965 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2008 | 514 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6310 | 0.020 |
Why?
|
Speech | 1 | 2009 | 548 | 0.010 |
Why?
|
Cause of Death | 1 | 1995 | 3723 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2013 | 22041 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20484 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2378 | 0.010 |
Why?
|
Mouth Neoplasms | 1 | 2009 | 593 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2016 | 1939 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 1995 | 2623 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2716 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1995 | 1455 | 0.010 |
Why?
|
DNA Copy Number Variations | 1 | 2013 | 2008 | 0.010 |
Why?
|
Primary Prevention | 1 | 2011 | 1207 | 0.010 |
Why?
|
Oxygen | 1 | 1995 | 4189 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 4900 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2013 | 4264 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2011 | 26168 | 0.010 |
Why?
|
Aspirin | 2 | 2007 | 3365 | 0.010 |
Why?
|
Tissue Survival | 1 | 2003 | 118 | 0.010 |
Why?
|
Cell Survival | 1 | 2013 | 5796 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10530 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2008 | 1745 | 0.010 |
Why?
|
Research | 1 | 2011 | 1973 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2008 | 1679 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 2186 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2011 | 1423 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36247 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4416 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 3758 | 0.010 |
Why?
|
Quebec | 1 | 2000 | 142 | 0.010 |
Why?
|
Maryland | 1 | 2000 | 275 | 0.010 |
Why?
|
Ischemia | 1 | 2008 | 1893 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1675 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10829 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1784 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4127 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2005 | 2897 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6067 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6540 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5396 | 0.010 |
Why?
|
Infant | 2 | 2011 | 36030 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18968 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16905 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6775 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5884 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15766 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 5790 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13629 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2000 | 3598 | 0.000 |
Why?
|
Animals | 1 | 2013 | 167940 | 0.000 |
Why?
|